About 3 Trademarks found for “VEQUANEX”

Pharmaceutical preparations for the prevention and/or treatment of the central nervous system, namely, central nervous system infections, brain diseases, central nervous system movement disorders, ocular motility disorders, spinal cord diseases; pharmaceutical preparations for the prevention and/or treatment of immunologic diseases, namely, autoimmune diseases, immunologic deficiency syndromes; pharmaceutical preparations for the prevention and/or treatment of cardiovascular diseases; pharmaceutical preparations for the prevention and/or treatment of diabetes; pharmaceutical preparations for the prevention and/or treatment of metabolic disorders, namely, diabetes, obesity, hyperlipidemia, insulin resistance, metabolic syndrome; anti-inflammatories; pharmaceutical preparations for the prevention and/or treatment of disorders of the respiratory system; pharmaceutical preparations for the prevention and/or treatment of disorders of the musculo-skeletal system; pharmaceutical preparations for the prevention and/or treatment of disorders of the genitourinary system; pharmaceutical preparations for use in dermatology, in oncology, in hematology, in transplantation, in ophthalmology, for use in the gastroenterological area and the prevention and treatment of ocular disorders or diseases; anti-infectives, anti-bacterials, antivirals, anti-biotics, anti-fungals.

Pharmaceutical preparations for the treatment of cardiovascular diseases; pharmaceutical preparations for the treatment of the respiratory system; pharmaceutical preparations for use in oncology; pharmaceutical preparations for use in ocular disorders; anti-infectives; antivirals; antibiotics; fungal medications.

Pharmaceutical preparations for the treatment of diseases and disorders of the central nervous system, namely central nervous system infections, brain diseases, central nervous system movement disorders, spinal cord diseases and ocular motility disorders; pharmaceutical preparations for the treatment of psychiatric diseases, namely mood, anxiety and cognitive disorders; pharmaceutical preparations for the treatment of urological, urogenital and urinary disorders; pharmaceutical preparations for the treatment of gastrointestinal disorders; pharmaceutical preparations for the treatment of musculo-skeletal disorders, namely connective tissue diseases, bone diseases, spinal diseases, back pain, fractures, sprains and cartilage injuries; pharmaceutical preparations for the treatment of dermatitis, skin pigmentation diseases, tissue and skin repair preparations and for anti-inflammatories, immunological preparations and ophthalmological preparations